
Press releases
30th Mar 2023
Genedrive® MT-RNR1 ID Test receives positive final recommendation by NICE
NICE issues final guidance for use in the NHS through Early Value Assessment programme...
20th Mar 2023
Genedrive® MT-RNR1 to commence roll out in Greater Manchester
genedrive plc (AIM:GDR), the point of care molecular diagnostics company, announces that the Ge...
9th Feb 2023
Antibiotic Induced Hearing Loss test receives preliminary recommendation by NICE
genedrive plc (AIM:GDR), the point of care molecular diagnostics company, announces that the UK...